Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Monica Escher Division of Clinical
Pharmacology and Toxicology
Emile Giostra Division of
Gastroenterology
Gilles Mentha Division of Visceral Surgery, Geneva
University Hospital, 1211 Geneva 14, Switzerland
Kava, the rhizome of the pepper plant Piper
methysticum, has been widely used in the South Pacific as a
narcotic drink. Lactones, the major constituents of kava, are
considered to be pharmacologically active and are sold in Europe and
the United States as standardised extracts for anxiety and tension.
A 50 year old man presented to his doctor because of jaundice. He had
noticed fatigue for a month, a "tanned" skin, and dark urine. The
medical history was unremarkable apart from slight anxiety, for which
he had been taking three to four capsules of kava extracts daily for
two months (maximum recommended dose three capsules) corresponding to a
dose of 210-280 mg lactones (Laitain, Schwabe, Switzerland). He took no
other drugs and did not consume alcohol. Liver function tests showed a
60-fold and 70-fold increase in aspartate aminotransferase and alanine
aminotransferase concentrations, respectively. Alkaline phosphatase
concentration was 430 IU/l (normal range 30-125),
Heavy consumption of kava has been associated with increased
concentrations of
-glutamyltransferase 691 IU/l (9-35), lactate dehydrogenase 1132 IU/l (125-240), and total and conjugated bilirubin 279.2 µmol/l
(6.8-25) and 212.3 µmol/l (1.7-8.6), respectively. Prothrombin
time was 25%. The patient was admitted to hospital. Ultrasonography
showed a slight increase in liver size but no ascites or portal vein
thrombosis. Blood tests for hepatitis A, B, C, and E, HIV,
cytomegalovirus, and Epstein-Barr virus gave negative results. The
patient's condition deteriorated within 48 hours. He developed stage
IV encephalopathy and had to be intubated. Prothrombin time was then
10%. The patient received a liver transplant two days later. He
recovered uneventfully. On examination the liver was atrophic, and the
subhepatic and portal veins were free. Histology showed extensive and
severe hepatocellular necrosis and extensive lobular and portal
infiltration of lymphocytes and numerous eosinophils.
-glutamyltransferase, suggesting potential hepatotoxicity.1 A case of recurring necrotising hepatitis has been reported.2 In our patient a relation between
ingestion of kava and fulminant hepatic failure is supported by the
chronology, histological findings, and exclusion of other causes of
hepatitis. Assessment of causality according to the definitions of the
World Health Organization is probable. Acute liver failure with a fatal outcome or that necessitates liver transplant has been attributed to
various herbal preparations.3-5 This case illustrates the importance of inquiring about the use of over the counter health products. It was reported to the Swiss Pharmacovigilance Center in Berne.
Footnotes
Competing interests: None declared.
References
| 1. | Mathews JD, Riley MD, Fejo L, Munoz E, Milns N, Gardner ID, et al. Effects of the heavy usage of kava on physical health: summary of a pilot survey in an Aboriginal community. Med J Aust 1988; 148: 548-555[Medline]. |
| 2. | Strahl S, Ehret V, Dahm HH, Maier KP. Necrotizing hepatitis after taking herbal medication. Dtsch Med Wschr 1998; 123: 1410-1414[Medline]. (In German.) |
| 3. | Mostefa-Kara N, Pauwels A, Pines E, Biour M, Levy VG. Fatal hepatitis after herbal tea. Lancet 1992; 340: 674[CrossRef][Medline]. |
| 4. | Yoshida EM, McLean CA, Cheng ES, Blanc PD, Somberg KA, Ferrell LD, et al. Chinese herbal medicine, fulminant hepatitis, and liver transplantation. Am J Gastroenterol 1996; 91: 2647-2648[Medline]. |
| 5. | Sheikh NM, Philen RM, Love LA. Chaparral-associated hepatotoxicity. Arch Intern Med 1997; 157: 913-919[Abstract]. |
Read all Rapid Responses
Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.